PetMed Express, Inc. (PETS)
NASDAQ: PETS · IEX Real-Time Price · USD
3.790
+0.075 (2.02%)
At close: Jul 19, 2024, 4:00 PM
3.890
+0.100 (2.64%)
Pre-market: Jul 22, 2024, 7:27 AM EDT
PetMed Express Revenue
In the fiscal year ending March 31, 2024, PetMed Express had annual revenue of $281.06M with 9.54% growth. Revenue in the quarter ending March 31, 2024 was $66.50M with 6.56% year-over-year growth.
Revenue (ttm)
$281.06M
Revenue Growth
+9.54%
P/S Ratio
0.28
Revenue / Employee
$979,317
Employees
287
Market Cap
78.10M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 281.06M | 24.49M | 9.54% |
Mar 31, 2023 | 256.58M | -15.70M | -5.77% |
Mar 31, 2022 | 272.28M | -31.30M | -10.31% |
Mar 31, 2021 | 303.58M | 19.46M | 6.85% |
Mar 31, 2020 | 284.13M | 706.00K | 0.25% |
Mar 31, 2019 | 283.42M | 9.62M | 3.51% |
Mar 31, 2018 | 273.80M | 24.62M | 9.88% |
Mar 31, 2017 | 249.18M | 14.49M | 6.18% |
Mar 31, 2016 | 234.68M | 5.29M | 2.31% |
Mar 31, 2015 | 229.40M | -4.00M | -1.71% |
Mar 31, 2014 | 233.39M | 5.56M | 2.44% |
Mar 31, 2013 | 227.83M | -10.42M | -4.37% |
Mar 31, 2012 | 238.25M | 6.61M | 2.85% |
Mar 31, 2011 | 231.64M | -6.62M | -2.78% |
Mar 31, 2010 | 238.27M | 18.85M | 8.59% |
Mar 31, 2009 | 219.41M | 31.08M | 16.50% |
Mar 31, 2008 | 188.34M | 26.09M | 16.08% |
Mar 31, 2007 | 162.25M | 24.66M | 17.93% |
Mar 31, 2006 | 137.58M | 29.23M | 26.97% |
Mar 31, 2005 | 108.36M | 14.36M | 15.28% |
Mar 31, 2004 | 93.99M | 39.02M | 70.98% |
Mar 31, 2003 | 54.97M | 22.95M | 71.66% |
Mar 31, 2002 | 32.03M | 22.02M | 220.06% |
Mar 31, 2001 | 10.01M | -4.67M | -31.82% |
Mar 31, 2000 | 14.68M | 4.45M | 43.55% |
Mar 31, 1999 | 10.22M | 6.73M | 192.66% |
Mar 31, 1998 | 3.49M | 2.89M | 480.14% |
Mar 31, 1997 | 602.19K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Eagle Pharmaceuticals | 257.55M |
MDxHealth | 75.33M |
SHL Telemedicine | 57.08M |
Marinus Pharmaceuticals | 28.29M |
Forian | 20.49M |
T2 Biosystems | 7.18M |
Affimed | 4.26M |
Genelux | 8.00K |
PETS News
- 27 days ago - PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 4 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS - Accesswire
- 5 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS - GlobeNewsWire
- 5 weeks ago - PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results - GlobeNewsWire
- 7 weeks ago - PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team - GlobeNewsWire
- 7 weeks ago - Pets At Home Purrs As FY Profits Meet Updated Guidance - Forbes
- 7 weeks ago - PetMed Express, Inc. Appoints Carla Dodds as New Chief Marketing Officer - GlobeNewsWire
- 2 months ago - PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2024 Earnings Call - GlobeNewsWire